As of May 22
| +0.26 / +7.28%|
The 1 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 6.80, with a high estimate of 6.80 and a low estimate of 6.80. The median estimate represents a +77.55% increase from the last price of 3.83.
The current consensus among 1 polled investment analysts is to Buy stock in ContraVir Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.